Johnson & Johnson - 10%+ Owner at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
CTNM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Johnson & Johnson since 12/23/2023

Holdings reported by Johnson & Johnson for Contineum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 1.98M $33.7M $17.05 Apr 9, 2024 Indirect

There are no transactions reported by Johnson & Johnson for Contineum Therapeutics, Inc.